Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Besana

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Heart Journal|February 1, 1994
Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancerG Fragasso, M Tresoldi, R Benti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferonC Besana, A Borri, E Bucci, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Relation between enzymatic activities and the degree of malignancy of human lymphomasP Vezzoni, R Giardini, M Raineri, et al.
The New England Journal of Medicine|June 1, 1989
Plasmapheresis in the treatment of stiff-man syndromeA M Vicari, F Folli, G Pozza, et al.
Tumori|December 23, 1998
Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trialF Boccardo, A Rubagotti, L Canobbio, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Heart Journal|February 1, 1994
Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancerG Fragasso, M Tresoldi, R Benti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferonC Besana, A Borri, E Bucci, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Relation between enzymatic activities and the degree of malignancy of human lymphomasP Vezzoni, R Giardini, M Raineri, et al.
The New England Journal of Medicine|June 1, 1989
Plasmapheresis in the treatment of stiff-man syndromeA M Vicari, F Folli, G Pozza, et al.
Tumori|December 23, 1998
Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trialF Boccardo, A Rubagotti, L Canobbio, et al.
Pageof 4